Evocatal and RohnerChem announce strategic partnership for enzymatic chemistry development and upscaling

06-Feb-2012 - Evocatal and RohnerChem combine their complementary services to offer customers a seamless solution for the development of high-performance biocatalytic processesand their rapid application in the synthesis of fine chemicals and API. The focus of this strategic partnership is to offer highly ...

Joint separation: Cooperation will extend service offerings of LANXESS subsidiary

04-Oct-2010 - Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients and ...

BASF celebrates anniversary of Minden site

75 years of active pharmaceutical ingredient production in Westphalia: a look back at the site's turbulent history

16-Sep-2010 - What do caffeine, theophylline and ephedrine have in common? All three active pharmaceutical ingredients are manufactured in the world's largest plants at BASF's Minden site. Numerous guests were invited to attend the on-site 75th anniversary celebration incorporating a tour of the production ...

Merck and Archimica start distribution partnership

12-Apr-2010 - Merck Schuchardt OHG, a subsidiary of Merck KGaA, and Archimica Group Holdings B.V. are entering into a close cooperation to provide building blocks and special reagents for Organic Synthesis via an exclusive distribution agreement. “The combination of Merck´s and Archimica´s strengths offers a ...

Evonik strengthens its exclusive synthesis business in US

Evonik acquires Eli Lilly and Company’s U.S. Tippecanoe manufacturing site

21-Oct-2009 - Evonik Industries AG has agreed to acquire Indianapolis, Indiana-based Eli Lilly and Company’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. The site, which employs about 700, manufactures active pharmaceutical ingredients (API) and precursor materials for the ...

Girindus sells activities in Kuensebeck to Central Glass

05-Jun-2008 - Girindus AG sold its industrial activities at the production site in Halle-Kuensebeck. Acquirer is Central Glass Germany GmbH, an affiliate of Central Glass Co., Ltd., Japan. Central Glass Germany GmbH takes over process development, upscaling, cGMP production of active pharmaceutical ingredients ...

Matrix Laboratories acquires residual holding in Mchem Group

28-Jan-2008 - Matrix Laboratories Limited, through its wholly owned subsidiary had, earlier, executed definitive agreements with the erstwhile promoter of MChem group of companies, China to acquire his residual shareholding in MChem group of companies. Consequent upon the receipt of the applicable approvals, ...

Hikal signs a manufacturing agreement with Pfizer

09-Jan-2008 - Hikal Ltd. announced that it has completed a contract manufacturing agreement for supply of active pharmaceutical ingredients (API's) with Pfizer Inc. "We are extremely pleased to be selected as a long term contract manufacturer by Pfizer", said Jai Hiremath, Vice Chairman & Managing Director of ...

DSM sells pharmaceutical production site in Michigan (USA) to Albemarle

21-Sep-2006 - DSM Pharmaceutical Products, a Business Group of Royal DSM NV, has signed an agreement with Albemarle Corporation regarding the sale of the assets and business associated with DSM's pharmaceutical production site in South Haven (Michigan - USA). Terms of the deal, which is targeted for closing ...

Production Restructuring, Innovation, and Capability Differentiation Key to the Success of Pharmaceutical Fine Chemicals

11-Sep-2006 - Focus on niche marketing, production streamlining, and research and development shall lead to success in the European market for fine chemicals. European companies face intense competition from Asian fine chemical suppliers, due to lack of capability differentiation and relatively higher fixed ...